[A practical guide for the use of psychopharmacologic agents. II. Antipsychotic and antiparkinson agents].
D000042:Absorption; D000367:Age Factors; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001341:Autonomic Nervous System / Q000187:drug effects; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001519:Behavior / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D004338:Drug Combinations; D004702:Endocrine Glands / Q000187:drug effects; D005128:Eye Diseases / Q000188:drug therapy; D006801:Humans; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D012871:Skin Diseases / Q000139:chemically induced; D013997:Time Factors
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D004338:Drug Combinations
Guide pratique pour l'emploi des agents psychopharmacologiques, II. Antipsychotiques et antiparkinsoniens